Fig. 2From: The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover studyChange over time during pimobendan treatment. Pre = pre-exercise; post = post-exercise. Pre-exercise NT-proBNP values at follow-up-investigations at day 90 (p = 0.0021) and 180 (p = 0.0175), and post-exercise values at day 90 (p = 0.0028) and 180 (p = 0.0016) in the treatment period with pimobendan decreased significantly in comparison to the baselineBack to article page